Cross posted from Nature Medicine’s Spoonful of Medicine blog
In August 2007, billionaire Carl Icahn took hold of 2.7 million of Biogen Idec’s shares, making him one of the company’s largest investors. Over the next few years, he grew his ownership in the Weston, Massachusetts-based biotech, holding 8.2 million shares valued at nearly $750 million as recently as June of this year. But yesterday, after four years of attempted control of the company’s direction and management, Icahn disclosed that he has dumped all of his stock in the company, according to the Wall Street Journal.
Read the full post over at Spoonful of Medicine.
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells